본문으로 건너뛰기
← 뒤로

Ionic Regulation of Mechanosurveillance and Metastasis via the MRTFA/KCNMB1 Axis.

bioRxiv : the preprint server for biology 2026

Gajda AM, Haloul M, Pai V, Mollaeian K, Patel KJ, Rodriguez-Lopez R, Beverley KM, Sanborn MA, Lee K, Castillo CC, Wilk SM, Wolska BM, Hossen F, Mendenhall EN, Lee JC, Levitan I, Rehman J, Er EE

📝 환자 설명용 한 줄

Cellular stiffness profoundly impacts cancer metastasis at multiple levels, but mechanisms that regulate cancer cells' stiffness remain poorly understood.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Gajda AM, Haloul M, et al. (2026). Ionic Regulation of Mechanosurveillance and Metastasis via the MRTFA/KCNMB1 Axis.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.01.13.699089
MLA Gajda AM, et al.. "Ionic Regulation of Mechanosurveillance and Metastasis via the MRTFA/KCNMB1 Axis.." bioRxiv : the preprint server for biology, 2026.
PMID 41648137

Abstract

Cellular stiffness profoundly impacts cancer metastasis at multiple levels, but mechanisms that regulate cancer cells' stiffness remain poorly understood. Here, we identified potassium efflux and KCNMB1, an auxiliary subunit of the large conductance potassium efflux (BK) channels, as regulators of cellular stiffness downstream of myocardin related transcription factor A (MRTFA). In primary pericytes, KCNMB1 knockdown increased cellular stiffness, which is consistent with the role of potassium efflux in promoting relaxation during excitation-contraction coupling. In a striking contrast, however, KCNMB1 knockdown decreased cellular stiffness in cancer cells. Softer cancer cells were resistant to NK cell mediated cytotoxicity and the low KCNMB1 expression was associated with worse survival in breast cancer patients. Importantly, pharmacological activation of BK channels reduced metastatic burden in mice and improved lysis of cancer cells by cytotoxic T-lymphocytes. These results highlight the unique ionic regulation of stiffness in cancer cells and point to BK channel agonism as a new therapeutic approach in cancer.